- About TRIUMF
- For the Public
- For Students
- For Scientific Visitors
- For the Media
- Careers at TRIUMF
- TRIUMF House
|Current Events||06 December 2013||
TRIUMF congratulates Dr. Michael Roney from the University of Victoria, lead for BaBar collaboration, was appointed to the directorship of the Institute of Particle Physics.
|Experimental Result||05 December 2013||
The laser spectroscopy group had its latest paper accepted into PRL. Francium isotopes are explored and a new experimental technique developed, paving the way for this recent success.
|Current Events||03 December 2013||
As part of the “Unveiling the Universe” lecture series, Dr. Paul Schaffer delivered a captivating talk on the science behind medical isotope production, how those isotopes are used today, and how they could be used in the future.
|Current Events||20 November 2013||
On November 13-15, the International Peer Review Committee visited TRIUMF to assess its performance, progress, and plans for the future.
|Awards & Honours||19 November 2013||
Theoretical physicist Dr. Petr Navratil is part of an international team set to receive an INCITE award, affording them crucial supercomputing resources for ab initio calculations of light nuclei reactions.
|Awards & Honours||14 November 2013||
The Minerva Foundation for BC Women announced Lia Merminga, Head of Accelerator Division, as a recipient of the Women In Science award. Lia is recognized for her integrity, excellence, and vision.
|Current Events||12 November 2013||
Chelsea, Ben and Sebastien received top honours at the annual Canadian Undergraduate Physics Conference, hosted by McMaster University this October.
|Current Events||01 November 2013||
Treating ocular melanoma since '95, the PT Facility at TRIUMF is one of just 42 facilities worldwide capable of supplying proton beams, the technical know-how, and coordination with local institutions to provide the best possible treatment for this rare disease.
|Awards & Honours||23 October 2013||
TRIUMF's Paul Schaffer was selected as one of Business in Vancouver's Top Forty under 40 this morning, recognizing BC professionals who've already made their mark. Congratulations!
|Experimental Result||21 October 2013||
For the first time ever, Astatine-209 was successfully recovered from TRIUMF's ISAC facility for use in nuclear medicine, a breakthrough in theranostic isotope research.